Similar articles

• A toxicological review of beta-adrenergic blockers.

  Jackson CD, Fishbein L. Jackson CD, et al. Fundam Appl Toxicol. 1986 Apr;6(3):395-422. doi: 10.1016/0272-0590(86)90214-9. Fundam Appl Toxicol. 1986. PMID: 2870945 Review.
• Comparative tolerability of labetalol versus propranolol, atenolol, pindolol, metoprolol, and nadolol.

  Burris JF, Goldstein J, Zager PG, Sutton JM, Sirgo MA, Plachetka JR. Burris JF, et al. J Clin Hypertens. 1986 Sep;2(3):285-93. J Clin Hypertens. 1986. PMID: 2878065 Clinical Trial.
• Labetalol, beta blockers, and acute deterioration of chronic airway obstruction.

  Adam WR, Meagher EJ, Barter CE. Adam WR, et al. Clin Exp Hypertens A. 1982;4(8):1419-28. doi: 10.3109/10641968209060799. Clin Exp Hypertens A. 1982. PMID: 6126285 Clinical Trial.
• High-pressure liquid chromatography of nadolol and other beta-adrenergic blocking drugs.

  Patel BR, Kirschbaum JJ, Poet RB. Patel BR, et al. J Pharm Sci. 1981 Mar;70(3):336-8. doi: 10.1002/jps.2600700332. J Pharm Sci. 1981. PMID: 6115047
• [Comparative pharmacokinetics of beta-blockers].

  Kiechel JR, Meier J. Kiechel JR, et al. Nouv Presse Med. 1978 Sep 20;7(31):2685-7. Nouv Presse Med. 1978. PMID: 30943 Review. French. No abstract available.